PaulaJBusseMD

Assistant Professor, Medicine, Icahn School of Medicine

Dr. Busse is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
5 E 98th St
New York, NY 10029
Phone+1 212-241-0764

Fax+1 212-534-0971

Icahn School of Medicine at Mount SinaiFellowship, Allergy and Immunology, 1999 - 2001
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1996 - 1999
University of Rochester School of Medicine and DentistryClass of 1996

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology

PubMed

The relationship between depressive symptoms and coping style on asthma outcomes in older adults.
Naomi Greenfield, Matthew Wysocki, Kimberly Arcoleo, Juliana Rodriguez, Sunit Jariwala
Journal of Behavioral Medicine. 2025-04-01
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting Obstacles.
Sandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, Paula J Busse, Timothy Craig
The Journal of Allergy and Clinical Immunology. in Practice. 2025-03-07
Asthma beliefs and overuse of short-acting beta-adrenergic receptor agonists among older adults.
Yoshiko Ishisaka, Jyoti Ankam, Jonathan Feldman, Paula Busse, Juan P Wisnivesky
The Journal of Asthma. 2025-02-01

Journal Articles

Effect of Lanadelumab Compared with Placebo on Prevention of Hereditary Angioedema Attacks
Jonathan A Bernstein, Lawrence B Schwartz, Andrew M Smith, H James Wedner, Daniel Soteres, Timothy Craig, Douglas T Johnston, Aleena Banerji, Paula J Busse, William R ..., JAMA

KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual MeetingMarch 3rd, 2025
Interim Phase 4 Data Support TAKHZYRO® (Lanadelumab) as an Effective Treatment to Reduce Attacks in Hereditary Angioedema PatientsFebruary 28th, 2022
$70m from NIAID to Establish Trial Site Network Focusing on Childhood Asthma in Low-Income Urban CommunitiesApril 26th, 2021
Join now to see all

Childhood Asthma in Urban SettingsICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2021–2028
Contribution Of Tnf-Alpha To Mucus Cell Production In AsthmaNational Institute Of Allergy And Infectious Diseases2010
C1 Esterase Inhibitor As Treatment And Prevention In Hereditary AngioedemaNational Center For Research Resources2009
Contribution Of Tnf-Alpha To Mucus Cell Production In AsthmaNational Institute Of Allergy And Infectious Diseases2006–2009
Change TrialNational Center For Research Resources2008
Efficacy And Safety Of Purified C1 Esterase Inhibitor For Treatment Of HaeNational Center For Research Resources2006–2007
An Ascending Four-Dose Placebo Controlled Study To Assess The Efficacy And To...National Center For Research Resources2004